Items Tagged ‘genomics’

October 1st, 2014

Genomic Health Announces Positive Results from Latest Clinical Validation Study of Oncotype DX® as Predictor of Near- and Long-term Outcomes in Racially Diverse Group of Prostate Cancer Patients

By

REDWOOD CITY, Calif., Sept. 29, 2014 – Genomic Health, Inc. (Nasdaq: GHDX) today announced strongly positive results from an additional independent clinical validation study of the Oncotype DX® prostate cancer test, conducted in collaboration with the Uniformed Services University of the Health Sciences’ (USU) Center for Prostate Disease Research (CPDR) supported by a multi-disciplinary team […]

View full entry

Tags: Early Stage I-II (A-B) Prostate Cancer, genomics, News, oncotype, Prostate Cancer


September 29th, 2014

Advances in Genomic Testing-What you Need to Know

By

Q: What is genomic testing? A: Genomic testing looks at a group of genes and their varying levels of expression. This gene expression or activity can characterize how genes interact with one another and predict the behavior of certain tissues within the body. This is in contrast to genetic testing, which looks at a specific change […]

View full entry

Tags: Adjuvant (I-III, A-C) Colon Cancer, Breast Cancer, Colon Cancer, Early Stage I-II (A-B) Prostate Cancer, General, genomics, News, Other News Topics (not Types of Cancer), Prostate Cancer, Stage I Node Negative Breast Cancer


September 22nd, 2014

Oncotype DX Colon Cancer Test May Reduce Medical Costs Associated with Stage II Disease While Increasing Patient Well-being

By

REDWOOD CITY, Calif., Sept. 12, 2014 /PRNewswire/ – Genomic Health, Inc. (Nasdaq: GHDX) today announced that PharmacoEconomics published positive results from a health economic analysis suggesting that use of the Oncotype® DX colon cancer test may result in a significant reduction in direct medical costs and improve patient quality of life by helping them avoid side effects of unnecessary treatment. “By […]

View full entry

Tags: Adjuvant (I-III, A-C) Colon Cancer, Colon Cancer, early stage colon cancer, genomics, News, oncotype, stage 2 colon cancer